Holen Sie sich die Stockscreener-App
0.8112
0.63%
0.0051
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TPST?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.8061
Offen:
$0.8239
24-Stunden-Volumen:
2.27M
Relative Volume:
0.99
Marktkapitalisierung:
$13.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.10M
KGV:
-0.1306
EPS:
-6.2098
Netto-Cashflow:
$-26.38M
1W Leistung:
-2.15%
1M Leistung:
-26.25%
6M Leistung:
-48.98%
1J Leistung:
-84.94%
1-Tages-Spanne:
$0.78
$0.85
1-Wochen-Bereich:
$0.78
$0.8513
52-Wochen-Spanne:
$0.7432
$6.115
Tempest Therapeutics Inc Stock (TPST) Company Profile
Firmenname
Tempest Therapeutics Inc
Sektor
Branche
Telefon
415-798-8589
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE
Compare TPST vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
0.8112 | 13.71M | 0 | -43.10M | -26.38M | -6.2098 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-04-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-08 | Eingeleitet | Jefferies | Buy |
Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten
Form 8K Tempest Therapeutics Inc For: 28 September By Investing.com - Investing.com Nigeria
Tempest Therapeutics Strengthens Governance and CAR-T Partnership Framework - TipRanks
H.C. Wainwright Maintains Tempest Therapeutics(TPST.US) With Buy Rating, Cuts Target Price to $7 - Moomoo
Tempest Therapeutics, Inc. (TPST) Stock Price, News, Quote & History - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - CNN
Tempest Therapeutics Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Tempest Therapeutics appoints Nancy Freda-Smith to board - Investing.com
Tempest Therapeutics appoints Nancy Freda-Smith to board By Investing.com - Investing.com UK
Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors - GlobeNewswire
$Tempest Therapeutics (TPST.US)$[Share Link: Join us in the TradersLink | Join main group chat.] - Moomoo
Tempest Therapeutics, Inc. Announces Appointment of Nancy Freda-Smith as Director and Chair of the Audit Committee - marketscreener.com
Tempest Therapeutics (TPST) Slides 14.57% to $0.83, Testing Support Near $0.79Synthetic Short - siam.in
Form 8K Tempest Therapeutics Inc For: 17 September By Investing.com - Investing.com Nigeria
Tempest Therapeutics Expands In Vivo CAR-T Collaboration - TipRanks
Tempest Therapeutics, Inc.Common Stock (NQ: TPST - The Chronicle-Journal
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
$Tempest Therapeutics (TPST.US)$ - Moomoo
TPST Stock Slides As Dilutive Financing Overhang Builds - StocksToTrade
$Tempest Therapeutics (TPST.US)$ i like the generosity ill 🦁 it everytime - Moomoo
Tempest Therapeutics (TPST) Stock Climbs Over 66% After Hours: Here's Why - webull.com
Live Tempest Therapeutics, Inc. (TPST) Technical Analysis - Traders Union
Tempest Therapeutics (TPST) Stock Surges Wednesday: What's Driving the Action? - Benzinga
TPST Stock Spikes As New In Vivo CAR-T Deal Ignites Momentum - StocksToTrade
Biotech Pre-Market Movers: MEDS, TPST, CUPR Chart The Course - RTTNews
TPST Stock Spikes As Tempest Therapeutics Bets On In Vivo CAR-T - StocksToTrade
TPST Stock Jumps As Tempest Strikes In Vivo CAR-T Deal - timothysykes.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
TPST Stock Jumps As Tempest Therapeutics Expands In Vivo CAR-T Pipeline - StocksToTrade
Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Tempest Therapeutics Shares Surge 66.53% After Hours on CAR-T DealTempest Therapeutics (NASDAQ:TPST) - Benzinga
After-Hours Movers Sept. 15, 2026: WAFU, TPST, NAMI Gain; SOBR, FEED Fall - ChartMill
Tempest Therapeutics Raises $2.5 Million in Private Placement - Minichart
Tempest Therapeutics Gains Option to License New In-Body CAR-T Technology From Senlang - marketscreener.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Form 8K Tempest Therapeutics Inc For: 15 September By Investing.com - Investing.com Nigeria
Tempest Therapeutics Announces New Private Warrant Financing - TipRanks
Tempest Therapeutics stock surges on Senlang CAR-T deal By Investing.com - Investing.com Canada
Tempest Therapeutics stock surges on Senlang CAR-T deal - Investing.com
Tempest Therapeutics enters option deal for CAR-T platform - Investing.com
Tempest Therapeutics enters option deal for CAR-T platform By Investing.com - Investing.com India
Tempest Therapeutics Announces Exclusive Option Agreement with Senlang for CD7-Targeted Lentiviral In Vivo CAR-T Platform and BCMA/GPRC5D Candidate - Quiver Quantitative
Tempest Therapeutics raises $2.5M in private placement By Investing.com - Investing.com Australia
Tempest Therapeutics, Inc. announced that it expects to receive $2.500001 million in funding - marketscreener.com
Tempest Therapeutics Announces Up to $7.5 Million Private Placement - markets.businessinsider.com
Tempest Therapeutics raises $2.5M in private placement - Investing.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Tempest Therapeutics secures $50M equity purchase agreement with Lincoln Park - scanx.trade
Tempest Therapeutics CEO to present at H.C. Wainwright Global Investment Conference - Bitget
A biotech CEO will speak Sept. 15; Tempest will archive the webcast - Stock Titan
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tempest Therapeutics Inc-Aktie (TPST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Angel Matthew | CEO and President |
Mar 24 '26 |
Buy |
2.16 |
231,482 |
500,001 |
231,482 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):